Anshul Mangal

Opinion author

Anshul Mangal is the president of Project Farma and Precision for Medicine’s Manufacturing Solutions and a board member at the Alliance for Regenerative Medicines, Alliance for mRNA Medicines and IQHQ.

Biopharma collage of scientist, deals, and pills

Opinion

When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?

Here’s how to assess whether to develop a new therapy by building a proprietary platform, acquiring another company or asset or partnering with an established entity.

April 24, 2024

6 min read

Anshul Mangal